Wonderful talk #AUA23 by KSridhar on molecular biomarkers in MIBC! Excellent work by Andrea Necchi PURE01 Tom Powles ABACUS, Nabucco, Dutreneo, BLASST1 Shilpa Gupta & others: differences in performance across trials: no clinical utility yet, work is ongoing Dr. Bishoy M. Faltas Hsieh Lab

Congrats @AminaZoubeidi

Meet golden boy Stephan! He + so many wonderful dogs are available MACC Nashville - #Nashville ‘s only city shelter. #AdoptaShelterPet day - save a life + bring bring joy to your home ♥️🐶♥️ #dogsftwitter #dogsofNashville #adoptme #FostersSaveLives

Huge fan now of Giannis Antetokounmpo and it applies to everyone one us irrespective of sports —“MJ played 15 years and won 6 championships, were the other 9 years a failure ?”

Attending Coaches v. #cancer tonight in #nashville!! Such a great event! TY 🙏🏻 ACS Nashville for inviting us ACS Research Pls keep up these great fundraising efforts to help Is fight #cancer! #cancerwarrior @VUMC_Cancer Vanderbilt University Medical Center @VUMCHemOnc #cancerresearch

Thank you ⁦Kimryn Rathmell⁩ for reminding me of why I love Nashville. ⁦ACS Research⁩ #CancerResearcHERs ⁦@VUMC_Cancer⁩ ⁦Dr. Cathy Eng⁩ ⁦@VUMCHemOnc⁩ ⁦@seandellacroce⁩ is amazing!

The perfect Mother’s Day card doesn’t exi—

Graduation is such a special time of year marking tremendous achievements. Dr. ⁦Dr. Brad Reinfeld, MD PhD⁩ MD, PHD is no exception - Dean’s Award, ⁦@VUMC_Cancer⁩ student award, ⁦nature⁩ … & a gem of a human to grace our lab for the past few years. ⁦Onward!

▶️A MUST SEE @vumc_medicine #grandrounds by the fantastic Stacie Dusetzina - Thurs 5/18 at 8a CST: “Improving Access to Prescription Drugs through Policy Change”. medicine.vumc.org/medicine-grand… @VUMC_Cancer Vanderbilt Health #HealthEquity Vanderbilt University

🌟Congratulations to the amazing Mariana Byndloss on her receipt of an inaugural HHMI Freeman Hrabowski Scolars Award 🌟 Vanderbilt Health Vanderbilt University Howard Hughes Medical Institute selects Vanderbilt’s Byndloss as early-career scholar news.vumc.org/2023/05/09/how… via @vumchealth

Come join the Vanderbilt team! We are looking for an early/mid-career GU Medical Oncologist with a bladder cancer focus. careercenter.asco.org/job/7618295/vu….

Today is my Birthday 🥳 Pls meet some of the friends I spent the day with 🐶 Volunteering at the shelter is a joy + a way to give back to the community. Shelters are overcrowded with amazing pups. Pls consider donating to or volunteering at your local shelter. 🙏 #dogsftwitter

Check out our 3rd paper on Cancer Cell: "Braking Bad: How Loss of SYNCRIP Drives Prostate Cancer's Mutational Chaos and Resistance." Discover how SYNCRIP, as an innate molecular brake, controls APOBEC-driven mutagenesis, tumor heterogeneity & resistance:sciencedirect.com/science/articl…

As presented at @asco #ASCO23 and now in The Lancet Oncology Zanidatamab for HER2-amplified, unresectable, locally advanced or meta... …rect-com.proxy.library.vanderbilt.edu/science/articl… Dr. Shubham Pant @DucreuxMichel #HPB #HER2 Zymeworks Inc. #patientcare #cancer #CancerResearch Laura Goff Thatcher Heumann

Congratulations to Thomas Li (G3), Evelyn Kandov (G2), and Riley Bergman (G4) on receiving their F30s!

Beautiful!! Congratulations Hsieh Lab !

Thanks for noticing Ronak H. Mistry, DO ! We are truly excited to have a new @VUMC_Medicine website to showcase all the incredible people and programs we have Vanderbilt Health - Kudos to @KrystynaBarnard and her team for such a great job!

My lab is immediately hiring a research assistant to primarily assist with animal model development related projects. Please RT! Apply if this is something you are interested in. jobs.bcm.edu/job/Houston-Se…

.Amer. Urol. Assn. has announced that Sam S. Chang, MD, MBA, will receive the Hugh Hampton Young Award, which is presented annually to an individual for outstanding contributions to the study of genitourinary tract diseases. Congratulations, Sam S. Chang MD, MBA! spr.ly/6018RRMRr

Can a snail’s pace win the race in prostate cancer? Paula Hurley Vanderbilt Health discover ASPN-triggered migration of prostate cancer cells that can be inhibited with HER2/HER3 antibody-drug conjugates in prostate cancer models. The figure shows general stain and protein/RNA labeling